DVA Submission to TGA Public Consultation on Medicinal Cannabis Regulatory Reform and Letter to Department of Health, Disability and Ageing

Written by Claude Haiku 5.5 from the extracted text on 21 Oct 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

The release comprises the Department of Veterans' Affairs submission to the Therapeutic Goods Administration's public consultation on medicinal cannabis regulatory reform, together with a covering letter to the Department of Health, Disability and Ageing. It sets out DVA's position on the Repatriation Pharmaceutical Benefits Scheme (RPBS), under which medicinal cannabis is funded as an unlisted product, and reports that the number of veteran card holders accessing it rose by 50%, from 8,000 in 2023-24 to 12,000 in 2024-25. The submission describes concerning prescribing and marketing practices by vertically integrated telehealth providers, including work with Ahpra's Rapid Regulatory Response Unit. It answers consultation questions on product quality, dosage forms, paediatric use and transition to the ARTG, and refers to proposed Framework changes, including in-person consultation requirements and THC and daily dosage caps. The excerpt shows no exemptions applied (ss 47C, 47F or 47G) and does not state which passages, if any, were redacted.